GGrantIndex
← Leaderboards

David Hastings Cribbs

University Of California Irvine

Google Scholar ↗PubMed ↗ORCID ↗
$19,482,668
Attributed
$27,955,334
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.8M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,955,334 · 9

By mechanism

R01$18,750,605 · 3
RF1$5,682,740 · 2
P01$2,597,360 · 2
R44$499,754 · 1
R21$424,875 · 1

Top collaborators

Most similar at University Of California Irvine

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposS DiseasePathologyImpaired CognitionAmyloid Beta-ProteinAnimal ModelBrainVaccinesAgedMouse ModelDementiaAntibodiesBlood VesselsElderlyProteinsRisk FactorsDepositionCerebrovascularAgingNeuropathologyCellsHemorrhageTg2576Immunotherapy

Grant awards (56)

Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers$499,754
R44 · FY2025 · AG · contact PI
Adverse Cerebrovascular Responses to Antibodies Targeting Beta-Amyloid$2,342,415
RF1 · FY2024 · NS · contact PI
Hemorheological Factors in Cerebral Ischemia$609,018
R01 · FY2022 · NS
Hemorheological Factors in Cerebral Ischemia$608,107
R01 · FY2021 · NS
Hemorheological Factors in Cerebral Ischemia$607,221
R01 · FY2020 · NS
Hemorheological Factors in Cerebral Ischemia$606,362
R01 · FY2019 · NS
Hypertensive Mechanisms of Cerebral Microbleeds$424,875
R21 · FY2019 · NS
Multiple Approaches to Abeta Vaccination in Animal Models$3,340,325
RF1 · FY2018 · AG
Hemorheological Factors in Cerebral Ischemia$619,153
R01 · FY2018 · NS
Combining AD Epitope Vaccine with Innate Immunity$616,130
R01 · FY2018 · NS
PICALM, Oligomeric Abeta and Inflammation in Neurovascular Pathogenesis in AD$264,325
P01 · FY2018 · AG · contact PI
Combining AD Epitope Vaccine with Innate Immunity$615,802
R01 · FY2017 · NS
PICALM, Oligomeric Abeta and Inflammation in Neurovascular Pathogenesis in AD$264,323
P01 · FY2017 · AG · contact PI
Combining AD Epitope Vaccine with Innate Immunity$10,210
R01 · FY2017 · NS
Combining AD Epitope Vaccine with Innate Immunity$617,150
R01 · FY2016 · NS
Hemorheological Factors in Cerebral Ischemia$546,630
R01 · FY2016 · NS
Multiple Approaches to Abeta Vaccination in Animal Models$334,765
R01 · FY2016 · AG · contact PI
PICALM, Oligomeric Abeta and Inflammation in Neurovascular Pathogenesis in AD$256,660
P01 · FY2016 · AG · contact PI
Combining AD Epitope Vaccine with Innate Immunity$622,995
R01 · FY2015 · NS
Hemorheological Factors in Cerebral Ischemia$546,630
R01 · FY2015 · NS
Multiple Approaches to Abeta Vaccination in Animal Models$324,721
R01 · FY2015 · AG · contact PI
PICALM, Oligomeric Abeta and Inflammation in Neurovascular Pathogenesis in AD$248,959
P01 · FY2015 · AG · contact PI
Combining AD Epitope Vaccine with Innate Immunity$646,763
R01 · FY2014 · NS
Hemorheological Factors in Cerebral Ischemia$543,055
R01 · FY2014 · NS
Multiple Approaches to Abeta Vaccination in Animal Models$334,765
R01 · FY2014 · AG · contact PI
PICALM, Oligomeric Abeta and Inflammation in Neurovascular Pathogenesis in AD$291,166
P01 · FY2014 · AG · contact PI
Hemorheological Factors in Cerebral Ischemia$526,076
R01 · FY2013 · NS
Combining AD Epitope Vaccine with Innate Immunity$404,429
R01 · FY2013 · NS · contact PI
Multiple Approaches to Abeta Vaccination in Animal Models$315,772
R01 · FY2013 · AG · contact PI
Hemorheological Factors in Cerebral Ischemia$543,387
R01 · FY2012 · NS
Combining AD Epitope Vaccine with Innate Immunity$433,515
R01 · FY2012 · NS · contact PI
Multiple Approaches to Abeta Vaccination in Animal Models$335,943
R01 · FY2012 · AG · contact PI
OLIGOMERIC AB AND INFLAMMATION IN NEUROVASCULAR PATHOGENESIS IN AD$256,418
P01 · FY2012 · AG · contact PI
Combining AD Epitope Vaccine with Innate Immunity$446,424
R01 · FY2011 · NS · contact PI
OLIGOMERIC AB AND INFLAMMATION IN NEUROVASCULAR PATHOGENESIS IN AD$256,532
P01 · FY2011 · AG · contact PI
Combining AD Epitope Vaccine with Innate Immunity$442,458
R01 · FY2010 · NS · contact PI
Multiple Approaches to Abeta Vaccination in Animal Models$428,214
R01 · FY2010 · AG · contact PI
OLIGOMERIC AB AND INFLAMMATION IN NEUROVASCULAR PATHOGENESIS IN AD$259,123
P01 · FY2010 · AG · contact PI
Combining AD Epitope Vaccine with Innate Immunity$422,898
R01 · FY2009 · NS · contact PI
Multiple Approaches to Abeta Vaccination in Animal Models$419,799
R01 · FY2009 · AG · contact PI
OLIGOMERIC AB AND INFLAMMATION IN NEUROVASCULAR PATHOGENESIS IN AD$253,918
P01 · FY2009 · AG · contact PI
Combining AD epitope vaccine with innate immunity$421,437
R01 · FY2008 · NS · contact PI
Multiple Approaches to Abeta Vaccination in Animal Models$407,576
R01 · FY2008 · AG · contact PI
OLIGOMERIC AB AND INFLAMMATION IN NEUROVASCULAR PATHOGENESIS IN AD$245,936
P01 · FY2008 · AG · contact PI
Combining AD epitope vaccine with innate immunity$421,423
R01 · FY2007 · NS · contact PI
Multiple Approaches to Abeta Vaccination in Animal Models$403,776
R01 · FY2007 · AG · contact PI
Combining AD epitope vaccine with innate immunity$421,368
R01 · FY2006 · NS · contact PI
Multiple Approaches to Abeta Vaccination in Animal Models$416,848
R01 · FY2006 · AG · contact PI
Combining AD epitope vaccine with innate immunity$418,833
R01 · FY2005 · NS
Multiple Approaches to ABeta Vaccination in Animal Mode*$376,104
R01 · FY2005 · AG
Combining AD epitope vaccine with innate immunity$418,393
R01 · FY2004 · NS
Multiple Approaches to ABeta Vaccination in Animal Mode*$376,104
R01 · FY2004 · AG
Multiple Approaches to ABeta Vaccination in Animal Mode*$376,104
R01 · FY2003 · AG
Multiple Approaches to ABeta Vaccination in Animal Mode*$376,104
R01 · FY2002 · AG
Multiple Approaches to ABeta Vaccination in Animal Mode*$18,135
R01 · FY2002 · AG
Approaches to ABeta Vaccination in Animal Models$370,008
R01 · FY2001 · AG